Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.
about
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Ryanodine channel complex stab ...... endent validation of efficacy.
@en
Ryanodine channel complex stab ...... endent validation of efficacy.
@nl
type
label
Ryanodine channel complex stab ...... endent validation of efficacy.
@en
Ryanodine channel complex stab ...... endent validation of efficacy.
@nl
prefLabel
Ryanodine channel complex stab ...... endent validation of efficacy.
@en
Ryanodine channel complex stab ...... endent validation of efficacy.
@nl
P2093
P2860
P356
P1433
P1476
Ryanodine channel complex stab ...... endent validation of efficacy.
@en
P2093
Ada Maria Massari
Anna Cozzoli
Annamaria De Luca
Antonella Liantonio
Arcangela Giustino
Christina Bell
Elena Conte
Giulia Maria Camerino
Jack Vandermeulen
Marina Filipovic
P2860
P304
P356
10.1096/FJ.201700182RRR
P407
P577
2018-01-03T00:00:00Z